BACTAFUZ-B 2% W/W + 0.1%W/W TOPICAL EXTERNAL CREAMS উগান্ডা - ইংরেজি - National Drug Authority

bactafuz-b 2% w/w + 0.1%w/w topical external creams

mankind pharma limited - fusidic acid + betamethasone valerate - topical external creams - 2% w/w + 0.1%w/w

Candiforce-100 100 mg Capsule ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

candiforce-100 100 mg capsule

mankind pharma ltd.; importer: i.e. medica, inc.; distributor: i.e. medica, inc. - itraconazole - capsule - 100 mg

None 100 mg Capsule ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

none 100 mg capsule

mankind pharma ltd.; importer: i.e. medica, inc.; distributor: i.e. medica, inc. - itraconazole - capsule - 100 mg

NITROFURANTOIN MACROCRYSTALS capsule মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

nitrofurantoin macrocrystals capsule

bluepoint laboratories - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin capsules (macrocrystals) are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli , enterococci, staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules (macrocrystals) and other antibacterial drugs, nitrofurantoin capsules (macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distributio